MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling
- 7 September 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 308, 120941
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82130092)
This publication has 40 references indexed in Scilit:
- Increased LEF1 Expression and Decreased Notch2 Expression Are Strong Predictors of Poor Outcomes in Colorectal Cancer PatientsDisease Markers, 2013
- The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancerOncogene, 2012
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Wnt signaling and colon carcinogenesis: Beyond APCJournal of Carcinogenesis, 2011
- Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer ImmunotherapyClinical Cancer Research, 2010
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesisJournal of Experimental Medicine, 2008
- microRNAs as oncogenes and tumor suppressorsDevelopmental Biology, 2007
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994